Home
About Us
History
Mission & Vision
Company Profile
Why Choose Us
Group Companies
Plants
Ravenbhel Biotech
Ravenbhel Healthcare Pvt. Ltd.
Macmillon Pharmaceuticals Ltd.
Plants Approval
Products
Search by Molecule
Search by Therapeutic Category
Pharmaceuticals
Domestic
Export
Finished
Semi-Finished/Bulk
Nutraceuticals
Innovation-R&D Center
Business Area
Contract Manufacturing
Formulation Development
Technology Transfer
International Business
Certifications
Export Countries
COPP’s List
Contact us
Employee Login
WhatsApp us
Doxophylline Sustained Release 400/650 mg
Doxophylline Sustained Release 400/650 mg
Posted on
April 14, 2023
by
ravenbhel
Post navigation
Previous
Next
©2023
Ravenbhel Healthcare Pvt. Ltd.
. All rights reserved.
Designed by
OXO Solutions®
